Tech Company Financing Transactions
Scienture Funding Round
On 5/7/2026, Scienture raised $11 million in funding from private investors.
Transaction Overview
Company Name
Announced On
5/7/2026
Transaction Type
Debt
Amount
$11,000,000
Round
Undisclosed
Investors
Proceeds Purpose
Scienture intends to utilize proceeds from the non-dilutive financing to advance the clinical development of innovative product candidates in its diverse R&D portfolio.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
20 Austin Boulevard, Commack
New York, NY 11725
USA
New York, NY 11725
USA
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
Scienture, LLC is a New York-based pharmaceutical company driven by a highly experienced team passionate about developing unique specialty products that are designed to bring enhanced value to patients and healthcare systems. Our diverse pipeline spans therapeutic areas, indications, and market segments. With strategic capabilities in R&D, manufacturing, sales, marketing, and commercial operations, we are a fully fitted company delivering innovative solutions across the healthcare landscape.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Shankar Hariharan
Browse more venture capital transactions:
Prev: 5/7/2026: Pit venture capital transaction
Next: 5/7/2026: EasyWin venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We do our best to record every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs